Mayne Pharma Group Ltd. (AU:MYX) has released an update.
Mayne Pharma Group Ltd. CEO Shawn Patrick O’Brien is set to present at the Citizens JMP Life Sciences Conference in New York City, highlighting the ASX-listed company’s advancements in novel pharmaceuticals and their 40-year history of drug delivery innovation. The presentation is scheduled for May 13, 2024, and will be accessible via webcast. Mayne Pharma also offers contract development and manufacturing services globally.
For further insights into AU:MYX stock, check out TipRanks’ Stock Analysis page.
